Lowering anti-dsDNA antibodies—what's new?

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Lupus

• Publication date

  2002-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1191/0961203302lu311rrPMID 12529055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

  2003cited by this paper
• α-Actinin Is a Cross-Reactive Renal Target for Pathogenic Anti-DNA Antibodies1

  2002cited by this paper
• Mechanism of Action of Combined Short-Term CTLA4Ig and Anti-CD40 Ligand in Murine Systemic Lupus Erythematosus1

  2002cited by this paper
• Induction of Autoantibody Production Is Limited in Nonautoimmune Mice1

  2002cited by this paper
• The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus.

  2002cited by this paper
• The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

  2002cited by this paper
• Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies.

  2002cited by this paper
• Plasma cells for a lifetime?

  2002cited by this paper
• An open study of B lymphocyte depletion in systemic lupus erythematosus.

  2002cited by this paper
• Ox40 Costimulation Enhances the Development of T Cell Responses Induced by Dendritic Cells In Vivo

  2002cited by this paper
• Autoimmune diseases.

  2001cited by this paper
• CpG-DNA derived from sera in systemic lupus erythematosus enhances ICAM-1 expression on endothelial cells

  2001cited by this paper
• B cell development pathways.

  2001cited by this paper
• An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study.

  2001cited by this paper
• Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity

  2001cited by this paper
• BDCA-2, a Novel Plasmacytoid Dendritic Cell–specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon α/β Induction

  2001cited by this paper
• Plasma cells: finding new light at the end of B cell development

  2001cited by this paper
• Lupus anti‐DNA autoantibodies cross‐react with a glomerular structural protein: a case for tissue injury by molecular mimicry

  2001cited by this paper
• A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

  2001cited by this paper
• Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

  2001cited by this paper
• Lymphocytes induce monocyte chemoattractant protein-1 production by renal cells after Fc gamma receptor cross-linking: role of IL-1beta.

  2001cited by this paper
• 4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy1

  2001cited by this paper
• Cutting Edge: Reversal of Murine Lupus Nephritis with CTLA4Ig and Cyclophosphamide1

  2001cited by this paper
• Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus.

  2001cited by this paper
• Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus.

  2001cited by this paper
• Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients.

  2001cited by this paper
• Long-term anti-CD154 dosing in nephritic mice is required to maintain survival and inhibit mediators of renal fibrosis

  2001cited by this paper
• Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.

  2001cited by this paper
• Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus1

  2001cited by this paper
• Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus.

  2001cited by this paper
• Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

  2001cited by this paper
• Delineating the genetic basis of systemic lupus erythematosus.

  2001cited by this paper
• Anti-DNA meets NMDA in neuropsychiatric lupus

  2001cited by this paper
• Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.

  2001cited by this paper
• Murine lupus genetics: lessons learned.

  2001cited by this paper
• BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF

  2001cited by this paper
• Clinical and pharmacological experience with LJP-394

  2001cited by this paper
• Lymphocytes induce monocyte chemoattractant protein‐1 production by renal cells after Fcγ receptor cross‐linking: role of IL‐1β

  2001cited by this paper
• Immune Complexes Present in the Sera of Autoimmune Mice Activate Rheumatoid Factor B Cells1

  2000cited by this paper
• CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus.

  2000cited by this paper
• Lymphoid tissue homing chemokines are expressed in chronic inflammation.

  2000cited by this paper
• Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis.

  2000cited by this paper
• Lessons from the NZM2410 Model and Related Strains

  2000cited by this paper
• Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells.

  2000cited by this paper
• CD1d-restricted mouse V alpha 14 and human V alpha 24 T cells: lymphocytes of innate immunity.

  2000cited by this paper
• T-cell function and migration. Two sides of the same coin.

  2000cited by this paper
• Autoimmune diseases

  2000cited by this paper
• Cutting Edge: A Role for CD1 in the Pathogenesis of Lupus in NZB/NZW Mice1

  2000cited by this paper
• Baff Mediates Survival of Peripheral Immature B Lymphocytes

  2000cited by this paper
• CD134L Engagement Enhances Human B Cell Ig Production: CD154/CD40, CD70/CD27, and CD134/CD134L Interactions Coordinately Regulate T Cell-Dependent B Cell Responses1

  2000cited by this paper
• CD1d-restricted mouse Vα14 and human Vα24 T cells: lymphocytes of innate immunity

  2000cited by this paper
• TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

  2000cited by this paper
• The potential use of peptides and vaccination to treat systemic lupus erythematosus

  2000cited by this paper
• Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains.

  2000cited by this paper
• Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB x NZW)F(1) mice.

  2000cited by this paper
• Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response

  2000cited by this paper
• Prognostic parameters for flare in systemic lupus erythematosus.

  2000cited by this paper
• Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells.

  1999cited by this paper
• CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40‐ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles

  1999cited by this paper
• BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth

  1999cited by this paper
• Role of NK cells and TGF-beta in the regulation of T-cell-dependent antibody production in health and autoimmune disease.

  1999cited by this paper
• The role of autoantibodies in the pathogenesis of lupus nephritis.

  1999cited by this paper
• Monocyte Chemoattractant Protein 1–Dependent Leukocytic Infiltrates Are Responsible for Autoimmune Disease in Mrl-Faslpr Mice

  1999cited by this paper
• Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations

  1999cited by this paper
• Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function.

  1998cited by this paper
• Long-lived plasma cells: a mechanism for maintaining persistent antibody production.

  1998cited by this paper
• Subsets of Transgenic T Cells That Recognize CD1 Induce or Prevent Murine Lupus: Role of Cytokines

  1998cited by this paper
• CD4 T Cell Cytokine Differentiation: The B Cell Activation Molecule, OX40 Ligand, Instructs CD4 T Cells to Express Interleukin 4 and Upregulates Expression of the Chemokine Receptor, Blr-1

  1998cited by this paper
• Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus.

  1998cited by this paper
• Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis.

  1998cited by this paper
• Antibodies to DNA.

  1998cited by this paper
• Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways.

  1997cited by this paper
• Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination.

  1997cited by this paper
• Nuclear Localization of Autoantibodies

  1997cited by this paper
• Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.

  1997cited by this paper
• Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.

  1997cited by this paper
• Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice.

  1996cited by this paper
• Nephritogenic autoantibodies in lupus: current concepts and continuing controversies.

  1996cited by this paper
• Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies?

  1996cited by this paper
• Mechanisms of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody.

  1996cited by this paper
• Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail.

  1996cited by this paper
• Murine glomerulotropic monoclonal antibodies are highly oligoclonal and exhibit distinctive molecular features.

  1996cited by this paper
• An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus.

  1996cited by this paper
• Prevention of relapses in systemic lupus erythematosus.

  1995cited by this paper
• The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix.

  1995cited by this paper
• Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.

  1995cited by this paper
• Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice.

  1995cited by this paper
• Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers.

  1995cited by this paper
• Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.

  1994cited by this paper
• Treatment of murine lupus with CTLA4Ig.

  1994cited by this paper
• Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.

  1993cited by this paper
• Systemic lupus erythematosus and the nervous system

  1993cited by this paper
• Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia.

  1992cited by this paper
• Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo.

  1992cited by this paper
• Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice.

  1992cited by this paper
• Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study.

  1991cited by this paper
• Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.

  1990cited by this paper
• Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum.

  1990cited by this paper
• A murine nephritogenic monoclonal anti‐DNA autoantibody binds directly to mouse laminin, the major non‐collagenous protein component of the glomerular basement membrane

  1989cited by this paper
• Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney.

  1989cited by this paper

• The spectrum of nuclear patterns with stained metaphase chromosome plate: morphology nuances, immunological associations, and clinical relevance

  2025cites this paper
• Paranasal sinus occupancy assessed from magnetic resonance images—associations with clinical indicators in patients with systemic lupus erythematosus

  2023cites this paper
• Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies

  2018cites this paper
• The diagnosis and clinical management of the neuropsychiatric manifestations of lupus.

  2016cites this paper
• Epitope spreading induced by immunization with synthetic SSB peptides

  2016cites this paper
• Recent advances and current state of immunotherapy in systemic lupus erythematosus

  2016cites this paper
• 2 - Physiopathologie du lupus érythémateux

  2013cites this paper
• The role of positive feedback loops involving anti-dsDNA and anti-anti-dsDNA antibodies in autoimmune glomerulonephritis.

  2013cites this paper
• Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity

  2013cites this paper
• Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients.

  2012cites this paper
• Monocyte Chemoattractant-1 as a Urinary Biomarker for the Diagnosis of Activity of Lupus Nephritis in Brazilian Patients

  2012cites this paper
• Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case–control study from a single center

  2010cites this paper
• Gene Expression Profiles in a Rabbit Model of Systemic Lupus Erythematosus Autoantibody Production

  2010cites this paper
• The role of B cells in lupus pathogenesis.

  2010cites this paper
• Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions

  2010cites this paper
• Modeling immune complex-mediated autoimmune inflammation.

  2010cites this paper
• BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled?

  2008cites this paper
• Autoreactive B cell development in the periphery

  2006cites this paper
• Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis

  2006cites this paper
• Plasma filtration.

  2005cites this paper
• Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.

  2005cites this paper
• 356 Treatment options for severe lupus nephritis

  2004cites this paper
• The role of pathogenic B-cell clones in antibody mediated autoimmune disorders.

  2004cites this paper
• Expression of the cytoplasmic tail of LMP1 in mice induces hyperactivation of B lymphocytes and disordered lymphoid architecture.

  2004cites this paper
• Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.

  2004cites this paper
• Treatment options for severe lupus nephritis.

  2004cites this paper
• Systemic lupus erythematosus

  2001cites this paper